38 related articles for article (PubMed ID: 733890)
21. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.
Perucca E
Ther Drug Monit; 1980; 2(4):331-44. PubMed ID: 7013166
[TBL] [Abstract][Full Text] [Related]
22. Recent progress in pharmacogenetics.
Vesell ES
Adv Pharmacol (1962); 1969; 7():1-52. PubMed ID: 4190237
[No Abstract] [Full Text] [Related]
23. Clinical pharmacokinetics of phenylbutazone.
Aarbakke J
Clin Pharmacokinet; 1978; 3(5):369-80. PubMed ID: 359213
[TBL] [Abstract][Full Text] [Related]
24. Polygenic factors controlling drug response.
Vesell ES
Med Clin North Am; 1974 Sep; 58(5):951-63. PubMed ID: 4138463
[No Abstract] [Full Text] [Related]
25. Overview of drug-protein binding.
Gillette JR
Ann N Y Acad Sci; 1973 Nov; 226():6-17. PubMed ID: 4588445
[No Abstract] [Full Text] [Related]
26. Influence of binding on drug metabolism and distribution.
Dayton PG; Israili ZH; Perel JM
Ann N Y Acad Sci; 1973 Nov; 226():172-94. PubMed ID: 4588440
[No Abstract] [Full Text] [Related]
27. Utility of clinical chemical determinations of drug concentrations in biological fluids.
Vessell ES; Passananti GT
Clin Chem; 1971 Sep; 17(9):851-66. PubMed ID: 4105897
[No Abstract] [Full Text] [Related]
28. Assessment of methods to identify sources of interindividual pharmacokinetic variations.
Vesell ES; Penno MB
Clin Pharmacokinet; 1983; 8(5):378-409. PubMed ID: 6194927
[TBL] [Abstract][Full Text] [Related]
29. Potential environmental chemical hazards. I. Drugs.
Fishbein L; Flamm WG
Sci Total Environ; 1972 May; 1(1):15-30. PubMed ID: 4568740
[No Abstract] [Full Text] [Related]
30. Catabolism in acute renal failure: importance of glucocorticoids and lysosomal enzymes.
Heidland A; Schaefer RM; Weipert J; Heidbreder E; Teschner M; Peter G; Horl WH
Adv Exp Med Biol; 1987; 212():41-55. PubMed ID: 3303855
[No Abstract] [Full Text] [Related]
31. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
Van Peer A; Belpaire F; Bogaert M
Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
[TBL] [Abstract][Full Text] [Related]
32. Drug kinetics and alcohol ingestion.
Sellers EM; Holloway MR
Clin Pharmacokinet; 1978; 3(6):440-52. PubMed ID: 31257
[TBL] [Abstract][Full Text] [Related]
33. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Sawada Y; Hanano M; Sugiyama Y; Iga T
J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
[TBL] [Abstract][Full Text] [Related]
34. [Genetically dependent variability of drug effects].
Goedee HW; Altland K
Med Klin; 1970 Aug; 65(35):1507-17. PubMed ID: 4933855
[No Abstract] [Full Text] [Related]
35. Clinical pharmacokinetics of phenytoin.
Richens A
Clin Pharmacokinet; 1979; 4(3):153-69. PubMed ID: 383353
[TBL] [Abstract][Full Text] [Related]
36. Drug protein binding and the nephrotic syndrome.
Gugler R; Azarnoff DL
Clin Pharmacokinet; 1976; 1(1):25-35. PubMed ID: 797490
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
